Follow Us:Respiratio 2019; 9 (1-2): 59-65
KARAKTERISTIKE OBOLJELIH OD GRIPE HOSPITALIZOVANIH U
KLINICI ZA INFEKTIVNE BOLESTI UNIVERZITETSKOG KLINIČKOG
CENTRA REPUBLIKE SRPSKE U PERIODU OD 01.01. DO
31.03.2019.GODINE
CHARACTERISTICS OF PATIENTS WITH INFLUENZA HOSPITALIZED IN AN INFECTIOUS
DISEASES CLINIC UNIVERSITY CLINICAL CENTRE OF THE REPUBLIC OF SRPSKA IN THE
PERIOD FROM JANUARY 1 THROUGH MARCH 31, 2019.
Snežana Ritan, Tatjana Roganović, Antonija Verhaz, Dragan Kasapović, Milan Petrović,
Vesna Kapetanović
Original research
Naučni članak
Sažetak: Retrospektivno su analizirane karakteristike 181 oboljelog od gripe hospitalizovanih u
Klinici za infektivne bolesti Univerzitetskog kliničkog centra Republike Srpske u periodu od 01.01. do
31.03.2019.godine. Prosječna životna dob je 55 godina, većina pacijenata je bila iz Banjaluke. Jedan
pacijent je bio vakcinisan protiv sezonskog gripa, a 108 je bolovalo od hronične bolesti.Većina
pacijenata je imalo povišenu tjelesnu temperaturu i kašalj, znatan broj mijalgije i glavobolju, a
gastrointestinalne i neurološke simptome je imao manji broj pacijenata. Uglavnom su hospitalizovani
pacijenti sa komplikacijama u smislu virusne ili bakterijske pneumonije (radiološki verifikovanu
pneumoniju je imalo 115 pacijenata) i pacijenti sa neurološkom simptomatologijom. Potvrdili smo
influenzu PCR-om kod 78 pacijenta. Oskigenoterapiju je zahtijevalo 59, a mehaničku ventilaciju devet
pacijenata. Respiratorno insuficijentni pacijenti koji na oksigenoterapiju putem maske za lice ili
nazalnog katetera nisu reagovali poboljšanjem saturacije hemoglobina kiseonikom, odmah su iz
prijemne ambulante Klinike za infektivne bolesti upućivani u Kliniku intenzivne medicine za nehirurške
grane (KIM), a devet pacijenata je po prijemu premješteno u KIM zbog razvoja akutnog respiratornog
distres sindroma (ARDS-a). Većina pacijenata je liječena antibiotikom (179), dok je antivirotikom
liječeno 76 pacijenata (zbog nedostatka antivirusne terapije, a određen broj se javio značajno kasnije od
preporučenog vremena za ordiniranje antivirusne terapije i to zbog komplikacija u vidu bakterijske
pneumonije). Od 181 pacijenta ozdravilo je 169, a bilo je 12 smrtnih ishoda.
Ključne riječi: gripa, pneumonija, respiratorna insuficijencija
Literatura
|
1. Paules C, Subbarao K. Influenza. Lancet.2017;390(10095):687-708. |
|
|
|
|
|
2. Blud A. Influenza virus. Transfus Med Hemother. 2009;36(1):32-9. [CrossRef] |
|
|
|
|
|
3. Rossman J, Lamb R. Influenza virus assembly and budding. Virology. 2011;411:229-4. Dawood F,Iuliano A, Reed C, et al. Estimated global mortalityassociated with the first 12 months of 2009 pandemic influenzaA H1N1 virus circulation: a modelling study. Lancet Infect Dis.2012;12(9):687-95. |
|
|
|
|
|
4. Canadian Institute for Health Information. The impact of theH1N1 pandemic on Canadian hospitals. 2010. https ://secure.cihi.ca/free_products/H1N1_AIB_final EN.pdf.Accessed 2018. |
|
|
|
|
|
5. World Health Organization. Seasonal influenza and influenza A(H1N1). http://www.who.int/ith/diseases/si_iAh1n 1/en/. 2018. |
|
|
|
|
|
6. TaubenbergerJ,Morens D. The pathology of influenza virusInfection.Annu Rev Pathol. 2008;3:499-522.
|
|
|
|
|
|
7. Guo X, Thomas P. New fronts emerge in the influenza cytokinestorm. SeminImmunopathol. 2017;39(5):541-50. [CrossRef] |
|
|
|
|
|
8. Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome ofhuman influenza A (H5N1) is associated with high viral load andhypercytokinemia. Nat Med. 2006;12(10):1203-7. [CrossRef] |
|
|
|
|
|
9. Centers for Disease Control and Prevention (CDC). Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:467. |
|
|
|
|
|
10. World Health Organization. Influenza-like illness in the United States and Mexico, 24 April 2009. http://www.who.int/csr/don/2009_04_24/en/index.html (Accessed on April 27, 2009). |
|
|
|
|
|
11. World Health Organization. World now at the start of 2009 influenza pandemic. http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html (Accessed on June 11, 2009). |
|
|
|
|
|
12. World Health Organization. In focus: H1N1 now in the post-pandemic period. August 10, 2010. http://www.who.int/csr/disease/swineflu/en/index.html (Accessed on September 21, 2010). |
|
|
|
|
|
13. Mubareka S, Lowen AC, Steel J, et al. Transmission of influenza virus via aerosols and fomites in the guinea pig model. J InfectDis 2009; 199:858. [CrossRef] |
|
|
|
|
|
14. Brankston G, Gitterman L, Hirji Z, et al. Transmission of influenza A in human beings. Lancet Infect Dis 2007; 7:257. |
|
|
|
|
|
15. Blachere FM, Lindsley WG, Pearce TA, et al. Measurement of airborne influenza virus in a hospital emergency department.Clin Infect Dis 2009; 48:438. [CrossRef] |
|
|
|
|
|
16. Wong BC, Lee N, Li Y, et al. Possible role of aerosol transmission in a hospital outbreak of influenza.Clin Infect Dis 2010; 51:1176. [CrossRef] |
|
|
|
|
|
17. Noti JD, Lindsley WG, Blachere FM, et al. Detection of infectious influenza virus in cough aerosols generated in a simulated patient examination room.Clin Infect Dis 2012; 54:1569. [CrossRef] |
|
|
|
|
|
18. Bischoff WE, Swett K, Leng I, Peters TR. Exposure to influenza virus aerosols during routine patient care. J Infect Dis 2013; 207:1037. [CrossRef] |
|
|
|
|
|
19. Yan J, Grantham M, Pantelic J, et al. Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community. Proc Natl AcadSciU S A2018; 115:1081. [CrossRef] |
|
|
|
|
|
20. US Centers for Disease Control and Prevention. Interim guidance on the use of influenza antiviral agents during the 2010-2011 influenza season http://www.cdc.ov/flu/professionals/antivirals/guidance/summary.htm (Accessed on December 28, 2010). |
|
|
|
|
|
21. Bischoff WE, Reid T, Russell GB, Peters TR.Transocular entry of seasonal influenza-attenuated virus aerosols and the efficacy of n95 respirators, surgical masks, and eye protection in humans. J Infect Dis 2011; 204:193. [CrossRef] |
|
|
|
|
|
22. Reed C, Chaves SS, Perez A, et al. Complications among adults hospitalized with influenza: a comparison of seasonal influenza and the 2009 H1N1 pandemic. Clin Infect Dis 2014; 59:166. [CrossRef] |
|
|
|
|
|
23. Feng Y, Hu L, Lu S, Chen Q, Zheng Y, Zeng D, et al. Molecular pathology analyses of two fatal human infections of avian influenza A (H7N9) virus. J Clin Pathol. 2015;68(1):57-63. doi: 10.1136/jclinpath-2014-202441. [CrossRef] |
|
|
|
|
|
24. Tanaka T, Takada T, Takagi D, Takeyama N, Kitazawa Y. Acute renal failure due to rhabdomyolysis associated with echovirus 9 infection: A case report and review of literature. Jpn J Med. 1989;28:237-42. [CrossRef] |
|
|
|
|
|
25. Martin A, Reade EP. Acute Necrotizing Encephalopathy Progressing to Brain Death in a Pediatric Patient with Novel Influenza A (H1N1) Infection. Clin Infect Dis. 2010; 50:50-2. [CrossRef] |
|
|
|
|
|
26. Gulati P, Saini L, Jawa A, Das CJ. MRI in H1N1 Encephalitis. Indian J Pediatr. 2013; 80:157-9. [CrossRef] |
|
|
|
|
|
27. Wilking AN, Elliott E, Garcia MN, Murray KO, Munoz FM. Central Nervous System Manifestations in Pediatric Patients With Influenza A H1N1 Infection During the 2009 Pandemic. Pediatr Neurol. 2014; 51:370-6. [CrossRef] |
|
|
|
|
|
28. Amin R, Ford-Jones E, Richardson SE, MacGregor D, Tellier R, Heurter H, et al. Acute Childhood Encephalitis and Encephalopathy Associated With Influenza - A Prospective 11-Year Review. Pediatr Infect Dis J. 2008; 27:390-5. [CrossRef] |
|
|
|
|
|
29. Zeng H, Quinet S, Huang W, Gan Y, Han C, He Y, et al. Clinical and MRI features of neurological complications after influenza A (H1N1) infection in critically ill children. Pediatr Radiol. 2013; 43:1182-9. [CrossRef] |
|
|
|
|
|
30. Lyon JB, Remigio C, Milligan T, Deline C. Acute necrotizing encephalopathy in a child with H1N1 influenza infection. Pediatr Radiol. 2010; 40:200-5. [CrossRef] |
|
|
|
|
|
31. Bustos BR, Andrade YF. Acute encephalopathy and brain death in a child with influenza A (H1N1) during the 2009 pandemic. Rev Chilena Infectol. 2010; 27:413-6. [CrossRef] |
|
|
|
|
|
32. Kim KJ, Park ES, Chang HJ, Suh M, Rha DW. Novel Influenza A (H1N1)-Associated Acute Necrotizing Encephalopathy: A Case Report. Ann Rehabil Med. 2013; 37:286-90. [CrossRef] |
|
|
|
|
|
33. Hong KW, Cheong HJ, Choi WS, et al. Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011-2012: hospital-based influenza morbidity & mortality (HIMM) surveillance. J Infect Chemother. 2014;29(1):9-14. [CrossRef] |
|
|
|
|
|
34. Viasus D, Paño-Pardo JR, Pachón J, et al. Pneumonia complicating pandemic (H1N1) 2009: risk factors, clinical features, and outcomes. Medicine (Baltimore) 2011; 90:328. [CrossRef] |
|
|
|
|
|
35. Jain S, Benoit SR, Skarbinski J, et al. Influenzaassociated pneumonia among hospitalized patients with 2009 pandemic influenza A (H1N1) virus--United States, 2009. Clin Infect Dis 2012; 54:1221. [CrossRef] |
|
Snežana Ritan
Klinika za infektivne bolesti
Univerzitetski klinički centar Republike Srpske
12 Beba bb, 78 000 Banja Luka
Telefon:+387 51 342490
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it.